Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy P Sheahan

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Antiviral Research|July 5, 2025
Meeting report: 38th international conference on antiviral research in Las Vegas, United States of America, March 17-21, 2025Robert Jordan, Nancie M Archin, Valeria Cagno, et al.
Molecular Cell|December 8, 2020
Genomic RNA Elements Drive Phase Separation of the SARS-CoV-2 NucleocapsidChristiane Iserman, Christine A Roden, Mark A Boerneke, et al.
Journal of Virology|November 6, 2025
Mouse-adapted SARS-CoV-2 Omicron BA.5 infection induces post-acute lung fibrosis in BALB/c miceJohn M Powers, Sarah R Leist, Naveenchandra Suryadevara, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Mouse Adapted Omicron BA.5 Induces A Fibrotic Lung Disease Phenotype in BALB/c MiceJohn M Powers, Sarah R Leist, Naveenchandra Suryadevara, et al.
The American Journal of Tropical Medicine and Hygiene|February 9, 2026
Varying Malaria Rapid Diagnostic Test Accuracy by Regional Transmission Level and Demographics in TanzaniaDanielle Wiener, Misago D Seth, Celine I Mandara, et al.
Medrxiv : the Preprint Server for Health Sciences|August 12, 2025
Varying Malaria Rapid Diagnostic Test Accuracy by Regional Transmission Level and Demographics in TanzaniaDanielle Wiener, Misago D Seth, Celine I Mandara, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2021
Molnupiravir, an Oral Antiviral Treatment for COVID-19William Fischer, Joseph J Eron, Wayne Holman, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2016
SARS-like WIV1-CoV poised for human emergenceVineet D Menachery, Boyd L Yount, Amy C Sims, et al.
The Journal of Experimental Medicine|November 19, 2020
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivoAlexandra Schäfer, Frauke Muecksch, Julio C C Lorenzi, et al.
Nature Communications|January 12, 2020
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoVTimothy P Sheahan, Amy C Sims, Sarah R Leist, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Antiviral Research|July 5, 2025
Meeting report: 38th international conference on antiviral research in Las Vegas, United States of America, March 17-21, 2025Robert Jordan, Nancie M Archin, Valeria Cagno, et al.
Molecular Cell|December 8, 2020
Genomic RNA Elements Drive Phase Separation of the SARS-CoV-2 NucleocapsidChristiane Iserman, Christine A Roden, Mark A Boerneke, et al.
Journal of Virology|November 6, 2025
Mouse-adapted SARS-CoV-2 Omicron BA.5 infection induces post-acute lung fibrosis in BALB/c miceJohn M Powers, Sarah R Leist, Naveenchandra Suryadevara, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Mouse Adapted Omicron BA.5 Induces A Fibrotic Lung Disease Phenotype in BALB/c MiceJohn M Powers, Sarah R Leist, Naveenchandra Suryadevara, et al.
The American Journal of Tropical Medicine and Hygiene|February 9, 2026
Varying Malaria Rapid Diagnostic Test Accuracy by Regional Transmission Level and Demographics in TanzaniaDanielle Wiener, Misago D Seth, Celine I Mandara, et al.
Medrxiv : the Preprint Server for Health Sciences|August 12, 2025
Varying Malaria Rapid Diagnostic Test Accuracy by Regional Transmission Level and Demographics in TanzaniaDanielle Wiener, Misago D Seth, Celine I Mandara, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2021
Molnupiravir, an Oral Antiviral Treatment for COVID-19William Fischer, Joseph J Eron, Wayne Holman, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2016
SARS-like WIV1-CoV poised for human emergenceVineet D Menachery, Boyd L Yount, Amy C Sims, et al.
The Journal of Experimental Medicine|November 19, 2020
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivoAlexandra Schäfer, Frauke Muecksch, Julio C C Lorenzi, et al.
Nature Communications|January 12, 2020
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoVTimothy P Sheahan, Amy C Sims, Sarah R Leist, et al.
Pageof 9